Phase 1 SLE - Systemic Lupus Erythematosus Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1
CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases
ANCA Associated Vasculitis (AAV)SLE - Systemic Lupus ErythematosusSSc-Systemic Sclerosis+3 more
Institute of Hematology & Blood Diseases Hospital, China12 enrolled1 locationNCT07315087
Recruiting
Phase 1Phase 2
MB-CART19.1 in Refractory SLE
SLE - Systemic Lupus Erythematosus
Miltenyi Biomedicine GmbH29 enrolled3 locationsNCT06189157
Recruiting
Phase 1
Safety and Efficacy Study of CC312 for Moderate to Severe SLE
SLE - Systemic Lupus Erythematosus
CytoCares Inc32 enrolled1 locationNCT07177911